Universe Pharmaceuticals INC
UPC
$5.94
-$1.15-16.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.94M | -2.81M | -3.67M | -6.65M | -9.62M |
| Total Depreciation and Amortization | 479.00K | 498.20K | 517.40K | 511.90K | 506.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 370.60K | 370.60K | 370.60K | 399.10K | 427.60K |
| Change in Net Operating Assets | -10.82M | -6.54M | -2.27M | 952.50K | 4.17M |
| Cash from Operations | -11.91M | -8.48M | -5.05M | -4.78M | -4.52M |
| Capital Expenditure | -481.00K | -373.90K | -266.80K | -270.90K | -275.00K |
| Sale of Property, Plant, and Equipment | 5.40K | 5.40K | 5.40K | 3.60K | 1.80K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.55M | -813.20K | -80.40K | -116.80K | -153.20K |
| Cash from Investing | -2.02M | -1.18M | -341.80K | -384.10K | -426.40K |
| Total Debt Issued | 11.75M | 11.01M | 10.27M | 11.25M | 12.23M |
| Total Debt Repaid | -18.57M | -17.06M | -15.54M | -11.74M | -7.94M |
| Issuance of Common Stock | 0.00 | 7.50M | 15.00M | 27.50M | 40.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -6.82M | 1.45M | 9.73M | 27.01M | 44.29M |
| Foreign Exchange rate Adjustments | 1.04M | 402.00K | -237.60K | -584.90K | -932.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.71M | -7.81M | 4.09M | 21.25M | 38.41M |